← TrialMatch
HomeTrials

Acu-TENS to Improve the Sleep Quality in People with Stroke

Post-stroke sleep disorder and motor/cognitive dysfunction are common complications that affect the quality of life of older patients. The proposed study investigates the effects of an acupuncture-like method applied to six bilateral acupoints on sleep quality, motor function and cognition in older adults with chronic

Condition(s)AcuTENS, Sleep Quality, Stroke
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryPost-stroke sleep disorder and motor/cognitive dysfunction are common complications that affect the quality of life of older patients. The proposed study investigates the effects of an acupuncture-like method applied to six bilateral acupoints on sleep quality, motor function and cognition in older adults with chronic stroke. The study will be a single-blind (i.e., only patients will be blinded about the research purpose) randomized controlled trial (i.e., patients receiving the treatment is chosen at random) with a pre-mid-post follow-up design and involve two parallel groups of post-stroke survivors (aged \> 55 years) diagnosed with insomnia. Participants will be randomly allocated in a 1:1 radio to two independent groups, i.e., a treatment group or placebo group, namely a transcutaneous
Who can participateInclusion Criteria: * aged between 55 and 85 yrs; * diagnosed with stroke by magnetic resonance imaging or computed tomographic scan longer than one year; * able to walk 6-m independently; * scored ≥18 but less or equal than 27 in mini-mental state examination (MMSE); * self-reported poor sleep quality (PSQI, scores ≥ 6) in the past four weeks. Exclusion Criteria: * have a cardiac pacemaker; * have a severe disease that precludes the receipt of Acu-TENS; * are taking medication that may affect measured outcomes; * have skin lesions, infection, or inflammation near selected acupoints; * are participating in other drug/treatment programs.
Ages55 Years to 85 Years
SexAll
Lead sponsorThe Hong Kong Polytechnic University
LocationsHong Kong, Hong Kong; Hong Kong, Hong Kong
Start date2022-12-01
NCT IDNCT05623137
Official listinghttps://clinicaltrials.gov/study/NCT05623137

🔍 Search all trials →